William Su

Icahn School of Medicine at Mount Sinai

Papers

1

Total Citations

10

H-Index

1

About

Dr. William Su is a surgical oncologist whose research focuses on the management of human papillomavirus-positive oropharyngeal cancer (HPV+ OPC), with a particular emphasis on transoral robotic surgery (TORS) and long-term patient outcomes. His most cited work, a 2020 study on long-term outcomes in patients with recurrent HPV+ OPC after upfront TORS, has garnered 10 citations and addresses a critical gap in understanding the disease course following surgical failure. This contribution is notable for characterizing the clinical trajectory of these patients, providing essential data that informs treatment decisions and prognostic discussions. Dr. Su’s research is highly impactful for head and neck surgeons and oncologists, as it refines the role of minimally invasive surgery in an era of de-escalation strategies for HPV-driven cancers. His work underscores the importance of precise surgical staging and surveillance, helping to shape evidence-based guidelines for managing recurrence. Through his focused investigations, Dr. Su advances the field’s ability to optimize outcomes for a growing patient population with favorable prognoses, making him a valuable voice in the evolving landscape of HPV+ OPC care.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Long‐term outcomes in patients with recurrent human papillomavirus‐positive oropharyngeal cancer after upfront transoral robotic surgery
10 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Icahn School of Medicine at Mount Sinai

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago